New combination immunotherapy against breast cancer

New combination

A new combination therapy against cancer has been investigated by a research team at the Medical University of Vienna led by Maria Sibilia. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod. This combination showed promising results in topically accessible tumors like melanoma and breast cancer models: The […]

Read More… from New combination immunotherapy against breast cancer

The secret life of CD4+ T cells: from helpers to melanoma fighters

CD4+

The secret life of CD4+ T cells: from helpers to melanoma fighters: Researchers have revealed unprecedented insights into CD4+ T cells, a type of immune cell, which show promise for immunotherapies against melanoma, the most severe form of skin cancer. In the study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) […]

Read More… from The secret life of CD4+ T cells: from helpers to melanoma fighters

Researchers discover control mechanism for melanoma skin cancer

control

Researchers discover control mechanism for melanoma skin cancer: How the intricacies of tissue memory T cells could be the future of immunotherapies and vaccines In a significant step forward in understanding the crucial role tissue-resident memory T (TRM) cells play in the immune system, researchers have for the first time described how the cells behave […]

Read More… from Researchers discover control mechanism for melanoma skin cancer